These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 4096489)

  • 41. The clinical value of glycated haemoglobin and glycated plasma proteins.
    Lester E
    Ann Clin Biochem; 1989 May; 26 ( Pt 3)():213-9. PubMed ID: 2669613
    [No Abstract]   [Full Text] [Related]  

  • 42. Determination of glycated plasma proteins in normal and diabetic subjects utilizing aminophenylboronic acid columns.
    Sobel DO; Shakir KM
    Diabete Metab; 1987; 13(6):575-81. PubMed ID: 3329119
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The effect of improved control on blood filtration properties and non-enzymatic glycosylation of erythrocyte proteins in type 2 diabetes.
    Yue DK; Capogreco C; McLennan SV; Turtle JR
    Diabet Med; 1989 Aug; 6(6):486-9. PubMed ID: 2527128
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [The effect of a structural modification in the membrane proteins on the lipid-protein interaction in human erythrocyte membranes].
    Gorbunov NV
    Biull Eksp Biol Med; 1993 Nov; 116(11):488-91. PubMed ID: 8312536
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Modifications induced by diabetes on the physicochemical and functional properties of erythrocyte plasma membrane.
    Mazzanti L; Rabini RA; Testa I; Bertoli E
    Eur J Clin Invest; 1989 Feb; 19(1):84-9. PubMed ID: 2543581
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Metabolic control may influence the increased superoxide generation in diabetic serum.
    Ceriello A; Giugliano D; Quatraro A; Dello Russo P; Lefèbvre PJ
    Diabet Med; 1991 Jul; 8(6):540-2. PubMed ID: 1653676
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Glycosylated albumin and glycosylated proteins: rapidly changing indices of glycaemia in diabetic pregnancy.
    Leiper JM; Talwar D; Robb DA; Lunan CB; MacCuish AC
    Q J Med; 1985 Jun; 55(218):225-31. PubMed ID: 4023170
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Mechanism of increased erythrocyte membrane fluidity during magnesium deficiency in weanling rats.
    Tongyai S; Rayssiguier Y; Motta C; Gueux E; Maurois P; Heaton FW
    Am J Physiol; 1989 Aug; 257(2 Pt 1):C270-6. PubMed ID: 2504048
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Dietary sardine oil increases erythrocyte membrane fluidity in diabetic patients.
    Kamada T; Yamashita T; Baba Y; Kai M; Setoyama S; Chuman Y; Otsuji S
    Diabetes; 1986 May; 35(5):604-11. PubMed ID: 3956887
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Glycated proteins in diabetes.
    Beisswenger PJ; Szwergold BS; Yeo KT
    Clin Lab Med; 2001 Mar; 21(1):53-78, vi. PubMed ID: 11321937
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Investigation of the mechanism underlying the variability of glycated haemoglobin in non-diabetic subjects not related to glycaemia.
    Gould BJ; Davie SJ; Yudkin JS
    Clin Chim Acta; 1997 Apr; 260(1):49-64. PubMed ID: 9101100
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Clinical utility of nonenzymatically glycosylated blood proteins as an index of glucose control.
    Schleicher ED; Gerbitz KD; Dolhofer R; Reindl E; Wieland OH; Edelmann E; Haslbeck M; Kemmler W; Walter H; Mehnert H
    Diabetes Care; 1984; 7(6):548-56. PubMed ID: 6510180
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Resorcylidene aminoguanidine improves the pathologically reduced fluidity of erythrocyte membranes in diabetes mellitus.
    Sikurová L; Dérerová J; Kvasnicka P; Waczulíková I; Cársky J; Ulicná O
    Pharmazie; 2000 Sep; 55(9):700-1. PubMed ID: 11031780
    [No Abstract]   [Full Text] [Related]  

  • 54. Lower levels of erythrocyte membrane fluidity in diabetic patients. A spin label study.
    Kamada T; Otsuji S
    Diabetes; 1983 Jul; 32(7):585-91. PubMed ID: 6305749
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Clinical significance of glycated erythrocyte membrane protein in the diagnosis of diabetes mellitus].
    Nakagawa S; Nakayama H
    Nihon Rinsho; 1990 Dec; 48 Suppl():432-8. PubMed ID: 2086918
    [No Abstract]   [Full Text] [Related]  

  • 56. Metabolic control may alter antithrombin III activity but not its plasma concentration in diabetes: a possible role for nonenzymatic glycosylation.
    Ceriello A; Giugliano D; Dello Russo P; Tirelli A; Passariello N; Sgambato S
    Diabetes Care; 1986; 9(1):32-5. PubMed ID: 3948645
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Abnormal membrane fluidity and acetylcholinesterase activity in erythrocytes from insulin-dependent diabetic patients.
    Testa I; Rabini RA; Fumelli P; Bertoli E; Mazzanti L
    J Clin Endocrinol Metab; 1988 Dec; 67(6):1129-33. PubMed ID: 2848052
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Decreased Ca2(+)-ATPase activity after glycosylation of erythrocyte membranes in vivo and in vitro.
    González Flecha FL; Bermúdez MC; Cédola NV; Gagliardino JJ; Rossi JP
    Diabetes; 1990 Jun; 39(6):707-11. PubMed ID: 2140803
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Non-enzymatic glycosylation of urinary proteins in type 1 (insulin-dependent) diabetes: correlation with metabolic control and the degree of proteinuria.
    Gragnoli G; Signorini AM; Tanganelli I
    Diabetologia; 1984 Jun; 26(6):411-4. PubMed ID: 6468792
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Fluidity of intact erythrocyte membranes. Correction for fluorescence energy transfer from diphenylhexatriene to hemoglobin.
    Plásek J; Cermáková D; Jarolím P
    Biochim Biophys Acta; 1988 Jun; 941(2):119-22. PubMed ID: 3382643
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.